Ameriprise Financial Inc. Cuts Position in USANA Health Sciences, Inc. (NYSE:USNA)

Ameriprise Financial Inc. cut its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 76,576 shares of the company's stock after selling 17,051 shares during the period. Ameriprise Financial Inc. owned about 0.40% of USANA Health Sciences worth $2,748,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after buying an additional 55,059 shares during the period. Pacer Advisors Inc. boosted its position in USANA Health Sciences by 8.8% during the fourth quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock valued at $21,247,000 after buying an additional 47,745 shares during the period. Pzena Investment Management LLC boosted its position in USANA Health Sciences by 3.6% during the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock valued at $39,015,000 after buying an additional 37,466 shares during the period. Jane Street Group LLC boosted its position in USANA Health Sciences by 330.0% during the fourth quarter. Jane Street Group LLC now owns 39,979 shares of the company's stock valued at $1,435,000 after buying an additional 30,681 shares during the period. Finally, Norges Bank purchased a new stake in USANA Health Sciences during the fourth quarter valued at about $953,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

USNA has been the subject of several analyst reports. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. DA Davidson cut their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research report on Thursday, February 27th. Finally, Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

USANA Health Sciences Stock Down 2.2%

Shares of NYSE:USNA traded down $0.67 during midday trading on Monday, hitting $29.20. 162,590 shares of the stock traded hands, compared to its average volume of 133,620. The stock has a market capitalization of $543.79 million, a PE ratio of 10.32, a P/E/G ratio of 0.93 and a beta of 0.60. The business's 50 day moving average is $27.43 and its two-hundred day moving average is $31.63. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $49.16.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million during the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the prior year, the firm posted $0.86 earnings per share. As a group, sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Walter Noot sold 6,291 shares of the company's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. Insiders sold a total of 21,653 shares of company stock valued at $676,337 over the last three months. Corporate insiders own 0.63% of the company's stock.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.